Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Helena Kwakwa, M.D.

Newlands Health

Disclosure(s): Viiv Healthcare: Grant/Research Support

Poster(s):

1268 - Efficacy, safety, and tolerability of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in adults with HIV-HBV infection - preliminary results
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET